Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palifermin to reduce oral mucositis after BEAM and autologous PBSCT in malignant lymphoma
2008-001833-87Phase 4Terminated
- Sponsor
- University Hospital Freiburg
- Start
- May 2008
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in lymphosarcoma and Burkitt lymphoma (BL) comparing Palifermin + best supportive care with Best supportive care alone (2 arms). Primary endpoint: Incidence of severe oral mucositis. Started May 2008; status: terminated.
02
Drugs
palifermin
03
Conditions
lymphosarcomaBurkitt lymphoma (BL)
Beyond the preview
Go deeper on 2008-001833-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001833-87.